$2.84 Billion is the total value of PFM Health Sciences, LP's 85 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 80.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ALXN | Buy | ALEXION PHARMACEUTICALS INC | $153,292,000 | +90.3% | 981,131 | +39.4% | 5.39% | +44.8% |
OM | Buy | OUTSET MED INC | $150,608,000 | +15.3% | 2,911,207 | +1.3% | 5.30% | -12.3% |
ABBV | Buy | ABBVIE INC | $99,309,000 | +126.0% | 926,823 | +84.7% | 3.49% | +71.9% |
HZNP | Sell | HORIZON THERAPEUTICS PUB L | $97,202,000 | -8.0% | 1,328,803 | -2.3% | 3.42% | -30.0% |
RCUS | Buy | ARCUS BIOSCIENCES INC | $87,575,000 | +101.4% | 3,373,460 | +33.0% | 3.08% | +53.2% |
ARKG | New | ARK ETF TRput | $83,934,000 | – | 900,000 | +100.0% | 2.95% | – |
ACAD | Buy | ACADIA PHARMACEUTICALS INC | $67,331,000 | +287.6% | 1,259,474 | +199.1% | 2.37% | +195.0% |
IQV | Buy | IQVIA HLDGS INC | $66,884,000 | +25.5% | 373,301 | +10.4% | 2.35% | -4.5% |
UHS | New | UNIVERSAL HLTH SVCS INCcl b | $60,781,000 | – | 442,044 | +100.0% | 2.14% | – |
LLY | New | LILLY ELI & CO | $59,203,000 | – | 350,645 | +100.0% | 2.08% | – |
AVTR | Buy | AVANTOR INC | $58,390,000 | +104.4% | 2,074,259 | +63.3% | 2.05% | +55.5% |
ICUI | Sell | ICU MED INC | $57,444,000 | +3.7% | 267,817 | -11.6% | 2.02% | -21.1% |
MRNA | Buy | MODERNA INCput | $56,414,000 | +564.6% | 540,000 | +350.0% | 1.98% | +405.1% |
GILD | Sell | GILEAD SCIENCES INC | $54,862,000 | -19.5% | 941,674 | -12.7% | 1.93% | -38.7% |
AZN | Buy | ASTRAZENECA PLCsponsored adr | $54,719,000 | +157.4% | 1,094,600 | +182.2% | 1.92% | +95.8% |
NVRO | Sell | NEVRO CORP | $53,997,000 | +21.8% | 311,940 | -2.0% | 1.90% | -7.3% |
MCK | New | MCKESSON CORP | $53,739,000 | – | 308,987 | +100.0% | 1.89% | – |
ANTM | Buy | ANTHEM INC | $52,735,000 | +89.8% | 164,238 | +58.8% | 1.86% | +44.4% |
HCA | Sell | HCA HEALTHCARE INC | $51,556,000 | +13.3% | 313,487 | -14.1% | 1.81% | -13.8% |
AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $47,987,000 | +14.4% | 51,850,000 | 0.0% | 1.69% | -13.0% | ||
ALXN | New | ALEXION PHARMACEUTICALS INCcall | $46,872,000 | – | 300,000 | +100.0% | 1.65% | – |
MRTX | Sell | MIRATI THERAPEUTICS INC | $45,906,000 | +11.0% | 209,006 | -16.1% | 1.62% | -15.5% |
EW | EDWARDS LIFESCIENCES CORP | $44,506,000 | +14.3% | 487,842 | 0.0% | 1.57% | -13.0% | |
BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0 | $43,210,000 | +2.0% | 40,300,000 | 0.0% | 1.52% | -22.4% | ||
New | NOVAVAX INCnote 3.750% 2/0 | $42,991,000 | – | 34,000,000 | +100.0% | 1.51% | – | |
HRTX | Buy | HERON THERAPEUTICS INC | $42,573,000 | +53.5% | 2,011,477 | +7.5% | 1.50% | +16.8% |
IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $40,570,000 | +2.0% | 171,028 | +2.4% | 1.43% | -22.4% |
THC | Buy | TENET HEALTHCARE CORP | $39,372,000 | +91.0% | 986,019 | +17.2% | 1.38% | +45.3% |
BIIB | New | BIOGEN INCcall | $39,178,000 | – | 160,000 | +100.0% | 1.38% | – |
DHR | Buy | DANAHER CORPORATION | $38,042,000 | +7.9% | 171,252 | +4.6% | 1.34% | -17.9% |
UNH | New | UNITEDHEALTH GROUP INC | $35,804,000 | – | 102,099 | +100.0% | 1.26% | – |
XLF | New | SELECT SECTOR SPDR TRcall | $35,025,000 | – | 1,188,100 | +100.0% | 1.23% | – |
PEN | Sell | PENUMBRA INC | $34,946,000 | -24.9% | 199,694 | -16.6% | 1.23% | -42.9% |
BMRN | Buy | BIOMARIN PHARMACEUTICAL INCcall | $32,594,000 | +49.7% | 371,700 | +29.9% | 1.15% | +13.9% |
HUM | HUMANA INC | $31,894,000 | -0.9% | 77,740 | 0.0% | 1.12% | -24.6% | |
AERI | AERIE PHARMACEUTICALS INC | $30,095,000 | +14.8% | 2,227,611 | 0.0% | 1.06% | -12.6% | |
GH | New | GUARDANT HEALTH INC | $29,369,000 | – | 227,876 | +100.0% | 1.03% | – |
MYOV | Buy | MYOVANT SCIENCES LTD | $28,896,000 | +227.4% | 1,046,212 | +66.5% | 1.02% | +149.3% |
BIIB | Buy | BIOGEN INC | $28,062,000 | +10.3% | 114,604 | +27.7% | 0.99% | -16.1% |
BMY | New | BRISTOL-MYERS SQUIBB CO | $27,993,000 | – | 451,275 | +100.0% | 0.98% | – |
BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $27,578,000 | -48.2% | 314,499 | -55.1% | 0.97% | -60.6% |
HSIC | Sell | HENRY SCHEIN INC | $26,420,000 | +11.7% | 395,161 | -1.8% | 0.93% | -15.0% |
LH | Sell | LABORATORY CORP AMER HLDGS | $26,075,000 | -3.4% | 128,100 | -10.6% | 0.92% | -26.5% |
PPD | Sell | PPD INC | $25,421,000 | -12.8% | 742,863 | -5.7% | 0.89% | -33.7% |
PFE | Buy | PFIZER INC | $25,219,000 | +43.6% | 685,125 | +43.2% | 0.89% | +9.2% |
NVAX | New | NOVAVAX INC | $24,076,000 | – | 215,908 | +100.0% | 0.85% | – |
TCRR | TCR2 THERAPEUTICS INC | $23,995,000 | +52.2% | 775,794 | 0.0% | 0.84% | +15.8% | |
ICLR | ICON PLC | $23,656,000 | +2.0% | 121,323 | 0.0% | 0.83% | -22.4% | |
WAT | New | WATERS CORP | $23,380,000 | – | 94,497 | +100.0% | 0.82% | – |
IOVA | New | IOVANCE BIOTHERAPEUTICS INCput | $23,200,000 | – | 500,000 | +100.0% | 0.82% | – |
JWS | New | JAWS ACQUISITION CORP | $22,389,000 | – | 1,669,565 | +100.0% | 0.79% | – |
MOH | Sell | MOLINA HEALTHCARE INC | $21,674,000 | -27.1% | 101,907 | -37.3% | 0.76% | -44.6% |
LUNG | New | PULMONX CORP | $20,260,000 | – | 302,631 | +100.0% | 0.71% | – |
CYTK | New | CYTOKINETICS INC | $20,181,000 | – | 971,151 | +100.0% | 0.71% | – |
CNC | New | CENTENE CORP DEL | $19,719,000 | – | 328,479 | +100.0% | 0.69% | – |
NVAX | New | NOVAVAX INCcall | $16,727,000 | – | 150,000 | +100.0% | 0.59% | – |
STTK | New | SHATTUCK LABS INC | $16,202,000 | – | 386,813 | +100.0% | 0.57% | – |
ATHA | Buy | ATHIRA PHARMA INC | $16,105,000 | +122.3% | 470,227 | +19.8% | 0.57% | +69.3% |
HZNP | New | HORIZON THERAPEUTICS PUB Lcall | $15,939,000 | – | 217,900 | +100.0% | 0.56% | – |
IONS | New | IONIS PHARMACEUTICALS INC | $14,893,000 | – | 263,412 | +100.0% | 0.52% | – |
ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $14,525,000 | +114.3% | 2,694,769 | +217.2% | 0.51% | +63.3% |
ZLAB | New | ZAI LAB LTDadr | $14,490,000 | – | 107,061 | +100.0% | 0.51% | – |
ACAD | New | ACADIA PHARMACEUTICALS INCcall | $14,434,000 | – | 270,000 | +100.0% | 0.51% | – |
KNTE | New | KINNATE BIOPHARMA INC | $13,601,000 | – | 341,905 | +100.0% | 0.48% | – |
CNST | Sell | CONSTELLATION PHARMCETICLS I | $13,526,000 | -48.4% | 469,664 | -63.7% | 0.48% | -60.8% |
DVAX | DYNAVAX TECHNOLOGIES CORP | $13,070,000 | +3.0% | 2,936,990 | 0.0% | 0.46% | -21.6% | |
SPRB | New | SPRUCE BIOSCIENCES INC | $12,868,000 | – | 529,311 | +100.0% | 0.45% | – |
MYOV | New | MYOVANT SCIENCES LTDcall | $11,366,000 | – | 411,500 | +100.0% | 0.40% | – |
MRTX | Sell | MIRATI THERAPEUTICS INCcall | $9,730,000 | -62.7% | 44,300 | -71.8% | 0.34% | -71.6% |
Sell | TRILLIUM THERAPEUTICS INC | $8,813,000 | -44.9% | 599,111 | -46.8% | 0.31% | -58.1% | |
SBTX | New | SILVERBACK THERAPEUTICS INC | $8,723,000 | – | 188,243 | +100.0% | 0.31% | – |
PACB | New | PACIFIC BIOSCIENCES CALIF INput | $8,301,000 | – | 320,000 | +100.0% | 0.29% | – |
RVMD | Sell | REVOLUTION MEDICINES INC | $8,279,000 | -34.0% | 209,116 | -42.0% | 0.29% | -49.8% |
CERT | New | CERTARA INC | $7,688,000 | – | 228,000 | +100.0% | 0.27% | – |
FLDM | FLUIDIGM CORP DEL | $6,338,000 | -19.3% | 1,056,343 | 0.0% | 0.22% | -38.6% | |
CRSP | New | CRISPR THERAPEUTICS AGput | $6,278,000 | – | 41,000 | +100.0% | 0.22% | – |
RCUS | Sell | ARCUS BIOSCIENCES INCcall | $6,160,000 | +49.7% | 237,300 | -1.1% | 0.22% | +14.2% |
BLSA | New | BCLS ACQUISITION CORP | $5,513,000 | – | 500,000 | +100.0% | 0.19% | – |
JYAC | New | JIYA ACQUISITION CORP | $5,150,000 | – | 500,000 | +100.0% | 0.18% | – |
OSH | New | OAK STR HEALTH INC | $4,431,000 | – | 72,451 | +100.0% | 0.16% | – |
NEVRO CORPnote 2.750% 4/0 | $3,666,000 | +16.3% | 2,000,000 | 0.0% | 0.13% | -11.6% | ||
AMWL | AMERICAN WELL CORPcl a | $3,293,000 | -14.5% | 130,000 | 0.0% | 0.12% | -34.8% | |
EDIT | New | EDITAS MEDICINE INC | $2,096,000 | – | 29,900 | +100.0% | 0.07% | – |
ACORDA THERAPEUTICS INCnote 1.750% 6/1 | $1,000,000 | -16.7% | 2,000,000 | 0.0% | 0.04% | -36.4% | ||
ALNA | ALLENA PHARMACEUTICALS INC | $364,000 | -13.5% | 284,285 | 0.0% | 0.01% | -31.6% | |
ZEN | Exit | ZENDESK INC | $0 | – | -67,034 | -100.0% | -0.32% | – |
ST | Exit | SENSATA TECHNOLOGIES HLDNG P | $0 | – | -193,585 | -100.0% | -0.39% | – |
ALLO | Exit | ALLOGENE THERAPEUTICS INC | $0 | – | -224,266 | -100.0% | -0.39% | – |
V | Exit | VISA INC | $0 | – | -43,468 | -100.0% | -0.40% | – |
SHOP | Exit | SHOPIFY INCcl a | $0 | – | -9,454 | -100.0% | -0.45% | – |
ITOS | Exit | ITEOS THERAPEUTICS INC | $0 | – | -406,467 | -100.0% | -0.46% | – |
KRTX | Exit | KARUNA THERAPEUTICS INC | $0 | – | -137,960 | -100.0% | -0.49% | – |
RNA | Exit | AVIDITY BIOSCIENCES, INC. | $0 | – | -441,155 | -100.0% | -0.51% | – |
IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -381,990 | -100.0% | -0.58% | – |
NEE | Exit | NEXTERA ENERGY INC | $0 | – | -47,151 | -100.0% | -0.60% | – |
APTV | Exit | APTIV PLC | $0 | – | -150,794 | -100.0% | -0.64% | – |
NVDA | Exit | NVIDIA CORPORATION | $0 | – | -25,911 | -100.0% | -0.65% | – |
AMZN | Exit | AMAZON COM INC | $0 | – | -5,342 | -100.0% | -0.78% | – |
DE | Exit | DEERE & CO | $0 | – | -76,336 | -100.0% | -0.78% | – |
NXPI | Exit | NXP SEMICONDUCTORS N V | $0 | – | -144,881 | -100.0% | -0.84% | – |
HOLX | Exit | HOLOGIC INC | $0 | – | -272,193 | -100.0% | -0.84% | – |
PKI | Exit | PERKINELMER INC | $0 | – | -147,000 | -100.0% | -0.85% | – |
MSFT | Exit | MICROSOFT CORP | $0 | – | -95,177 | -100.0% | -0.93% | – |
GILD | Exit | GILEAD SCIENCES INCcall | $0 | – | -350,000 | -100.0% | -1.02% | – |
XBI | Exit | SPDR SER TRput | $0 | – | -200,000 | -100.0% | -1.03% | – |
MRK | Exit | MERCK & CO. INCcall | $0 | – | -340,000 | -100.0% | -1.30% | – |
SQ | Exit | SQUARE INCcl a | $0 | – | -181,509 | -100.0% | -1.36% | – |
PFE | Exit | PFIZER INCcall | $0 | – | -926,000 | -100.0% | -1.57% | – |
QQQ | Exit | INVESCO QQQ TRput | $0 | – | -381,500 | -100.0% | -4.90% | – |
IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -1,343,570 | -100.0% | -5.28% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-02-19
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MOLINA HEALTHCARE INC | 41 | Q3 2023 | 2.2% |
HCA HOLDINGS INC | 38 | Q3 2023 | 5.2% |
HUMANA INC | 37 | Q3 2023 | 3.8% |
EDWARDS LIFESCIENCES CORP | 36 | Q3 2023 | 3.3% |
UNITEDHEALTH GROUP INC | 33 | Q3 2023 | 4.8% |
PENUMBRA INC | 33 | Q3 2023 | 4.8% |
AERIE PHARMACEUTICALS INC | 28 | Q2 2022 | 3.7% |
TENET HEALTHCARE CORP | 27 | Q3 2023 | 2.3% |
ELEVANCE HEALTH INC | 26 | Q3 2023 | 4.2% |
ICON PLC | 26 | Q3 2023 | 2.5% |
View PFM Health Sciences, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Adaptimmune Therapeutics PLC | February 14, 2023 | ? | ? |
Arcus Biosciences, Inc. | February 14, 2023 | ? | ? |
Axsome Therapeutics, Inc. | February 14, 2023 | ? | ? |
Erasca, Inc. | February 14, 2023 | ? | ? |
Generation Bio Co. | February 14, 2023 | ? | ? |
IO Biotech, Inc. | February 14, 2023 | ? | ? |
Jounce Therapeutics, Inc. | February 14, 2023 | ? | ? |
Outset Medical, Inc. | February 14, 2023 | ? | ? |
uniQure N.V. | February 14, 2023 | ? | ? |
AERIE PHARMACEUTICALS INC | February 14, 2022 | ? | ? |
View PFM Health Sciences, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G | 2023-04-21 |
View PFM Health Sciences, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.